Panacea Index Logo

Command Palette

Search for a command to run...

Advances in the treatment of psychiatric disorders in long-term care homes.

Current opinion in psychiatry
November 1, 2010
David K Conn et al. (2 authors)
Journal ArticleReviewHuman Study
Study Details

Study Goal

The researchers aimed to evaluate the effectiveness of melatonin in managing behavioral symptoms of dementia in older adults in long-term care settings.

Results Summary

The study found negative results regarding melatonin's efficacy in managing behavioral symptoms of dementia, indicating it did not demonstrate significant benefits in this context.

Population

Older adults in long-term care homes with behavioral symptoms of dementia.

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (13)
InterventionDirectionEndpointPopulationDosageImpactClaim #
psychosocial interventions
decrease
behavioral symptoms
older adults in long-term care (LTC) homes
-
some evidence to support the use
#1
sensory interventions such as aromatherapy and calming music
decrease
behavioral symptoms
older adults in long-term care (LTC) homes
-
some evidence to support the use
#2
behavioral management techniques
decrease
behavioral symptoms
older adults in long-term care (LTC) homes
-
some evidence to support the use
#3
cognitive stimulation
decrease
behavioral symptoms
older adults in long-term care (LTC) homes
-
some evidence to support the use
#4
physical activity
decrease
behavioral symptoms
older adults in long-term care (LTC) homes
-
some evidence to support the use
#5
staff training
decrease
behavioral symptoms
older adults in long-term care (LTC) homes
-
some evidence to support the use
#6
psychotherapies such as reminiscence therapy and cognitive behavior therapy
decrease
depression
older adults in long-term care (LTC) homes
-
some evidence to support the use
#7
antipsychotic aripiprazole
neutral
behavioral symptoms of dementia
older adults in long-term care (LTC) homes
-
studies of
#8
prazosin
neutral
behavioral symptoms of dementia
older adults in long-term care (LTC) homes
-
studies of
#9
medication-discontinuation
neutral
behavioral symptoms of dementia
older adults in long-term care (LTC) homes
-
trials
#10
melatonin
no change
behavioral symptoms of dementia
older adults in long-term care (LTC) homes
-
negative studies involving
#11
oxcarbazepine
no change
behavioral symptoms of dementia
older adults in long-term care (LTC) homes
-
negative studies involving
#12
psychosocial interventions
decrease
behavioral symptoms associated with dementia
older adults in long-term care (LTC) homes
small or moderate
may confer significant benefits
#13
Abstract

PURPOSE OF REVIEW: Psychiatric disorders are common among older adults in long-term care (LTC) homes and the LTC population is rapidly growing in many countries. Treatment of psychiatric conditions in this population is challenging given the psychosocial environment and physical frailty of the population. This review highlights some important advances in pharmacological and nonpharmacological interventions in this setting. RECENT FINDINGS: There is some evidence to support the use of psychosocial interventions for behavioral symptoms, including those utilizing sensory interventions such as aromatherapy and calming music; behavioral management techniques; cognitive stimulation; physical activity; and staff training. There is also some evidence to support the use of psychotherapies such as reminiscence therapy and cognitive behavior therapy for depression. Recent literature on the pharmacological management of behavioral symptoms of dementia have included studies of the antipsychotic aripiprazole, prazosin, and medication-discontinuation trials along with two negative studies involving melatonin and oxcarbazepine. SUMMARY: The literature on psychosocial interventions for behavioral symptoms associated with dementia has been criticized for lack of vigor, but there is growing evidence from studies with improved methodology that these interventions may confer significant benefits, although the effect sizes are often small or moderate. More well designed trials of pharmacological therapies in the LTC population are also necessary.

Medical Subject Headings (MeSH)
AgedAnticonvulsantsAntipsychotic AgentsBehavior TherapyDementiaHomes for the AgedHumansMental DisordersNursing HomesSocial Support
Study Links
Quality Scores
SafetyNot Assessed
Efficacy20/10
Quality70/10
Citation Metrics
Total Citations13
Citations/Year0.9
Relative Citation Ratio0.50
NIH Percentile27%
Research Impact Scores
APT Score0.50
Weight Score1.12
Normalized Score0.42
Related Supplements